These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 28137271)

  • 1. Microwave ablation combined with OK-432 induces Th1-type response and specific antitumor immunity in a murine model of breast cancer.
    Li L; Wang W; Pan H; Ma G; Shi X; Xie H; Liu X; Ding Q; Zhou W; Wang S
    J Transl Med; 2017 Jan; 15(1):23. PubMed ID: 28137271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antitumor efficacy through microwave ablation in combination with immune checkpoints blockade in breast cancer: A pre-clinical study in a murine model.
    Zhu J; Yu M; Chen L; Kong P; Li L; Ma G; Ge H; Cui Y; Li Z; Pan H; Xie H; Zhou W; Wang S
    Diagn Interv Imaging; 2018 Mar; 99(3):135-142. PubMed ID: 29398572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of microwave ablation and cell immunotherapy induces nonspecific immunity of hepatocellular carcinoma model mice.
    Duan X; Wang M; Han X; Ren J; Huang G; Ju S; Zhang Q
    Cell Cycle; 2020 Dec; 19(24):3595-3607. PubMed ID: 33283623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer.
    Zhou W; Yu M; Pan H; Qiu W; Wang H; Qian M; Che N; Zhang K; Mao X; Li L; Wang R; Xie H; Ling L; Zhao Y; Liu X; Wang C; Ding Q; Wang S
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective strategy of dendritic cell-based immunotherapy for advanced tumor-bearing hosts: the critical role of Th1-dominant immunity.
    Mashino K; Sadanaga N; Tanaka F; Ohta M; Yamaguchi H; Mori M
    Mol Cancer Ther; 2002 Aug; 1(10):785-94. PubMed ID: 12492111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation and immunostimulant OK-432: combination therapy enhances systemic antitumor immunity for treatment of VX2 lung tumors in rabbits.
    Hamamoto S; Okuma T; Yamamoto A; Kageyama K; Takeshita T; Sakai Y; Nishida N; Matsuoka T; Miki Y
    Radiology; 2013 May; 267(2):405-13. PubMed ID: 23440322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microwave ablation combined with anti-PD-1 therapy enhances systemic antitumor immunity in a multitumor murine model of Hepa1-6.
    Huang S; Li T; Chen Y; Liu J; Wang Y; Yang C; Wang C; Ju S; Bai Y; Yao W; Xiong B
    Int J Hyperthermia; 2022; 39(1):278-286. PubMed ID: 35129044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OK-432 synergizes with IFN-γ to confer dendritic cells with enhanced antitumor immunity.
    Pan K; Lv L; Zheng HX; Zhao JJ; Pan QZ; Li JJ; Weng DS; Wang DD; Jiang SS; Chang AE; Li Q; Xia JC
    Immunol Cell Biol; 2014 Mar; 92(3):263-74. PubMed ID: 24296809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
    Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microwave ablation combined with anti-PD-1/CTLA-4 therapy induces an antitumor immune response to renal cell carcinoma in a murine model.
    Guo RQ; Peng JZ; Li YM; Li XG
    Cell Cycle; 2023 Jan; 22(2):242-254. PubMed ID: 35980140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microwave ablation combined with PD-L1 blockade synergistically promotes Cxcl9-mediated antitumor immunity.
    He N; Huang H; Wu S; Ji W; Tai Y; Gao R; Liu Y; Liu Y; Chen L; Zhu D; Zheng X; Jiang J
    Cancer Sci; 2024 Jul; 115(7):2196-2208. PubMed ID: 38655660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of systemic and local immunization with a CTL-directed peptide in combination with a local injection of OK-432.
    Ono T; Harada M; Yamada A; Tanaka M; Takao Y; Tanaka Y; Mine T; Sakamoto K; Nakashima T; Itoh K
    Clin Cancer Res; 2006 Feb; 12(4):1325-32. PubMed ID: 16489090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells.
    Okamoto M; Ohe G; Furuichi S; Nishikawa H; Oshikawa T; Tano T; Ahmed SU; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
    Anticancer Res; 2002; 22(6A):3229-39. PubMed ID: 12530069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
    Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S
    J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells.
    Tkach M; Coria L; Rosemblit C; Rivas MA; Proietti CJ; Díaz Flaqué MC; Beguelin W; Frahm I; Charreau EH; Cassataro J; Elizalde PV; Schillaci R
    J Immunol; 2012 Aug; 189(3):1162-72. PubMed ID: 22753933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemoradiotherapy for patients with oral squamous cell carcinoma: augmentation of OK-432-induced helper T cell 1 response by 5-FU and X-ray irradiation.
    Tano T; Okamoto M; Kan S; Bando T; Goda H; Nakashiro K; Shimodaira S; Koido S; Homma S; Fujita T; Sato M; Yamashita N; Hamakawa H; Kawakami Y
    Neoplasia; 2013 Jul; 15(7):805-14. PubMed ID: 23814492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination Therapy of Pulsed-Wave Ultrasound Hyperthermia and Immunostimulant OK-432 Enhances Systemic Antitumor Immunity for Cancer Treatment.
    Li TC; Liu CC; Lee YZ; Hsu YH; Chiang CF; Miaw SC; Lin WL
    Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):140-149. PubMed ID: 32339644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct immunoreactions after a primary tumor microwave ablation using different heating parameters in a VX2 tumor model.
    Qian M; Lyu J; Da X; Zhu C; Wang G; Fang Y; Xu J
    J Cancer Res Ther; 2023 Dec; 19(6):1620-1626. PubMed ID: 38156930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
    Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
    Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation of liver tumors in combination with local OK-432 injection prolongs survival and suppresses distant tumor growth in the rabbit model with intra- and extrahepatic VX2 tumors.
    Kageyama K; Yamamoto A; Okuma T; Hamamoto S; Takeshita T; Sakai Y; Nishida N; Matsuoka T; Miki Y
    Cardiovasc Intervent Radiol; 2013 Oct; 36(5):1383-92. PubMed ID: 23737021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.